CClinicalTrials.gg
CompletedNCT04301245Updated Jun 1, 2020

Profile of COPD Patients Refusing Educational Program in Pulmonary Rehabilitation and Impact on the Benefits

An observational study in Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation, sponsored by ADIR Association. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-06-01.

Sponsored by ADIR Association · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
201
Ages
18 Years and older
Sex
All
01

Study summary

Pulmonary rehabilitation (PR) has proven its efficacy to improve dyspnea, health status, exercise tolerance and quality of life for patients with stable Chronic Obstructive Pulmonary Disease (COPD). Exercise training has previously been thoroughly studied but education has been less studied in PR. Furthermore, only few studies have investigated the added value of an educational program (EP) to exercise training on clinical and physical factors. Characterizing those patients who refuse EP is therefore a first step to better target them and potentially improve their adherence and outcome following PR.

The aim of this study was to determine the characteristics of the COPD patients referred to PR who refused EP compare to those who accepted and to identify the independent predictive factors of refusal. The investigators also sought to compare the change in clinical outcomes and number and length of hospitalization at six months following PR among those patients who accepted or not to participate in EP.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Rehabilitation

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Rehabilitation
  • Education
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 201 is above the median of 157 across 929 observational studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

ADIR Association is the lead sponsor of 26 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients referred for pulmonary rehabilitation between July 2015 and July 2019 to ADIR Association, Rouen University Hospital, France

Inclusion criteria

  • Clinical diagnosis of COPD,
  • >18 years old,
  • Stable state of COPD.

Exclusion criteria

Exclusion Criteria:

  • Patients who have not been offered an educational program
  • Patients who have already been offered an educational program during a pulmonary rehabilitation in the same center.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
201 participants (actual)
Patient registry
No

Groups and cohorts

  • ETEP group

    Exercise Training and Educational Program (ETEP) group. Patients who accepted the educational program in addition to the exercise training.

    Other: Educational program

  • ET group

    Exercise Training (ET) group. Patients who refused the educational program and did only the exercise training.

    Other: Educational program

Interventions

  • OtherEducational program

    The educational program (EP) was offered during the initial session of the pulmonary rehabilitation. According to the french law, patients were free to participate or not. The EP consisted of an educational diagnosis, educational workshops and an individual final assessment.

06

What researchers measure

Primary outcomes

  1. Multiple logistic regression between the variables defined and the refusal of educational program

    The variables are described below in primary outcomes

    Time frame: Baseline

  2. Gender

    Gender will be analysed in logistic regression.

    Time frame: Baseline

  3. Age

    Age will be analysed in logistic regression.

    Time frame: Baseline

  4. Height

    Height will be analysed in logistic regression.

    Time frame: Baseline

  5. Weight

    Weight will be analysed in logistic regression.

    Time frame: Baseline

  6. Body mass index

    Body mass index will be analysed in logistic regression.

    Time frame: Baseline

  7. COPD stages

    COPD stages will be analysed in logistic regression.

    Time frame: Baseline

  8. Forced Expiratory Volume in one second

    Forced Expiratory Volume in one second will be analysed in logistic regression.

    Time frame: Baseline

  9. Forced Vital Capacity

    Forced Vital Capacity will be analysed in logistic regression.

    Time frame: Baseline

  10. Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity

    Ratio between Forced Expiratory Volume in one second and Forced Vital Capacity will be analysed in logistic regression.

    Time frame: Baseline

  11. Total Lung Capacity

    Total Lung Capacity will be analysed in logistic regression.

    Time frame: Baseline

  12. Residual Volume

    Residual Volume will be analysed in logistic regression.

    Time frame: Baseline

  13. Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume

    Diffusing capacity of the lungs for carbon monoxide divided by alveolar volume will be analysed in logistic regression.

    Time frame: Baseline

  14. Comorbidities

    Comorbidities will be analysed in logistic regression.

    Time frame: Baseline

  15. Tabacco status

    Tabacco status will be analysed in logistic regression.

    Time frame: Baseline

  16. Tabacco consumption

    Tabacco consumption will be analysed in logistic regression.

    Time frame: Baseline

  17. Prescription of oxygen

    Prescription of oxygen will be analysed in logistic regression.

    Time frame: Baseline

  18. Prescription of non invasive ventilation

    Prescription of non invasive ventilation will be analysed in logistic regression.

    Time frame: Baseline

  19. Arterial oxygen partial pressure

    Arterial oxygen partial pressure will be analysed in logistic regression.

    Time frame: Baseline

  20. Arterial carbon dioxide partial pressure

    Arterial carbone dioxide partial pressure will be analysed in logistic regression.

    Time frame: Baseline

  21. Location of the training sessions

    Location of the training sessions will be analysed in logistic regression.

    Time frame: Baseline

  22. Ambulance transport

    Number of patients with an ambulance transport will be analysed in logistic regression.

    Time frame: Baseline

  23. Distance between patient's home and center

    Distance between patient's home and center will be analysed in logistic regression.

    Time frame: Baseline

  24. Dyspnea

    Dyspnea assessed by the modified Medical Research Council scale will be analysed in logistic regression.

    Time frame: Baseline

  25. 6-Minute Stepper Test

    Number of steps during the 6-Minute Stepper Test will be analysed in logistic regression.

    Time frame: Baseline

  26. 6-Minute Walk Test

    Distance during the 6-Minute Walk Test will be analysed in logistic regression.

    Time frame: Baseline

  27. Maximal oxygen consumption

    Maximal oxygen consumption during cardiopulmonary exercise testing will be analysed in logistic regression.

    Time frame: Baseline

  28. Maximal workload

    Maximal workload achieved during cardiopulmonary exercise testing will be analysed in logistic regression.

    Time frame: Baseline

  29. Saint George's Respiratory Questionnaire

    Quality of life assessed by Saint George's Respiratory Questionnaire will be analysed in logistic regression.

    Time frame: Baseline

  30. Employment

    Employment will be analysed in logistic regression.

    Time frame: Baseline

  31. Educational level

    Educational level assessed by the international classification "Classification Internationale Type de l'Education" will be analysed in logistic regression.

    Time frame: Baseline

  32. Cognitive impairment

    Cognitive impairment assessed by the Montreal Cognitive Assessment will be analysed in logistic regression.

    Time frame: Baseline

  33. Anxiety and depression level

    Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression.

    Time frame: Baseline

Secondary outcomes

  1. 6-Minute Stepper Test

    Change in number of steps during the 6-Minute Stepper Test will be compared between groups.

    Time frame: 2 months

  2. 6-Minute Walk Test

    Change in distance during the 6-Minute Walk Test will be compared between groups.

    Time frame: 2 months

  3. Saint George's Respiratory Questionnaire

    Change in Saint George's Respiratory Questionnaire will be compared between groups.

    Time frame: 2 months

  4. Anxiety and depression level

    Anxiety and depression level assessed by the Hospital Anxiety and Depression scale will be analysed in logistic regression.

    Time frame: 2 months

  5. Cognitive impairment

    Change in cognitive impairment assessed by the Montreal Cognitive Assessment will be compared between groups.

    Time frame: 2 months

  6. Number of hospitalizations

    Number of hospitalizations will be compared between groups.

    Time frame: 6 months

  7. Number of hospitalized patients

    Number of hospitalized patients will be compared between groups.

    Time frame: 6 months

  8. Number of days of hospitalization

    Number of days of hospitalization will be compared between groups.

    Time frame: 6 months

  9. Attendance rate at educational sessions

    Attendance rate at education sessions will be analysed

    Time frame: 2 months

07

Study locations

1 site
  • ADIR Association
    Bois-Guillaume, France
08

References and documents

Publications

  • Smondack P, Gravier FE, Combret Y, Muir JF, Cuvelier A, Debeaumont D, Medrinal C, Prieur G, Bonnevie T. Factors influencing participation in educational workshops as part of a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease: a retrospective study. Expert Rev Respir Med. 2022 Mar;16(3):341-349. doi: 10.1080/17476348.2022.1991793. Epub 2021 Nov 2. PubMed 34623218 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04301245
Lead sponsor
ADIR Association
Responsible party
Sponsor
First posted
Mar 10, 2020
Start date
Feb 28, 2020
Primary completion
Mar 31, 2020
Completion
Apr 10, 2020
Last update
Jun 1, 2020

Study contacts

Jean-François Muir, MD PhD
principal investigator · ADIR Association, Rouen University Hospital, Rouen, France;Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France
Antoine Cuvelier, MD PhD
study chair · Normandie University, Rouen University Hospital, Haute-Normandie Research and Biomedical Innovation, Rouen, France ; Pulmonary, Thoracic Oncology and Respiratory Intensive Care Department, Rouen University Hospital, Rouen, France.
David Debeaumont, MD
study chair · Department of Respiratory and Exercise Physiology and CICCRB 1404, Rouen University Hospital, Rouen France.
Tristan Bonnevie, PT MSc
study chair · ADIR Association, Rouen University Hospital, Rouen, France ; Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute- Normandie Research and Biomedical Innovation, Rouen, France.
Francis-Edouard Gravier, PT MSc
study chair · ADIR Association, Rouen University Hospital, Rouen, France ; Normandie University, UNIROUEN, UPRES EA 3830, Rouen University Hospital, Haute- Normandie Research and Biomedical Innovation, Rouen, France
Pauline Smondack, PT
study chair · ADIR Association, Rouen University Hospital, Rouen, France.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion